Hong Kong stock anomaly | Concord Jere Pharmaceutical -B (09966.HK) has increased by more than 15%, and will announce its mid-term performance next Thursday, expected to turn losses into profits of not less than 20 million yuan.

According to the Wise Finance and Economics APP, Kangning Jeri Pharmaceuticals-B (09966.HK) saw its closing gain further expand, rising by 14.03% to 10.81 Hong Kong dollars as of the time of publication, with a trading volume of 73.8646 million Hong Kong dollars.